Lisa M. Mandrusiak
Oblon
Articles
Supreme Court Declines to Hear Idenix Case: Dispute Surrounding the Enablement Standard for Biotechnology Patents Continues
USA - February 12 2021 On January 19, 2021, the Supreme Court denied a petition for certiorari to hear the Idenix Pharmaceuticals LLC v. Gilead Sciences Inc. case (941 F.3d…
PTAB Trends and Predictions: Looking Back at 2020 and Forward to 2021
USA - January 29 2021 2020 was a busy year at the PTAB. Despite the many issues facing us all during the COVID-19 pandemic, the overall number of AIA-trial filings…
Should Companies Suspend Patent Rights on COVID-19 Vaccines?
USA - December 21 2020 In early October, Moderna earned praise by announcing that it will not enforce patent rights related to its mRNA coronavirus vaccine during the…
Supreme Court Hears Oral Arguments on Affordable Care Act: Will Biosimilars Survive?
USA - November 10 2020 Today the Supreme Court heard arguments in Texas v. Azar that the Affordable Care Act (ACA)’s individual coverage mandate is unconstitutional…
Where Have All the Bio/Pharma IPRs Gone?
USA - October 27 2020 The IPR program in general has been wildly successful in its intended purpose of providing a lower-cost alternative to patent litigation, and the…
